Bed sores, also known as pressure sores and pressure ulcers, are one of the most common clinical complications and a "persistent disease" that needs to be overcome in nursing research. However, with the introduction of cell growth-promoting peptide (CGPP) by Guangzhou Wanli Medical Technology Co., Ltd., this worldwide medical problem has been solved.

Bed sores often occur in patients who have been bedridden for a long time, such as traumatic fractures, surgery patients, and paralysis caused by stroke. Due to the decline of immunity and long-term pressure on local tissues of the body, the metabolic balance is broken, and continuous ischemia, hypoxia, and malnutrition lead to tissue ulceration and necrosis. Bed sores are a common problem in rehabilitation and nursing care. It is said that about 20% of hospitalized patients will suffer from bedsores. The prevention and care techniques are very complicated, and it is not a simple problem that can be eliminated with a single rule. Bed sores are chronic wounds that are prone to drug resistance. Therefore, the treatment takes a long time, is difficult and expensive, and even skin grafting cannot bring about improvement. Once the wound infection causes other complications, it is very dangerous. According to relevant literature reports, about 60,000 people die of decubitus complications every year in the world, and the mortality rate of elderly patients with decubitus is four times that of those without decubitus.

Why do you say that Guangzhou Wanli Medical Technology Co., Ltd. has solved this worldwide problem?

Let's first look at cell growth-promoting peptide (CGPP). This is a new type of medical bioengineering material developed by the scientific research team of Wanli Medical. It has the following unique functions:

First, the unique Taikinin in the cell growth-promoting peptide (CGPP) can induce the synthesis of various proteins in the body. What kind of protein is lacking, which kind of protein will be synthesized, such as collagen, elastin and so on. In this way, it can ensure that the quantity, quality and speed of protein synthesis in the cells are in a normal state, meet the nutritional needs of the skin, and promote the regeneration of new tissues.

Second, the body tissue festers, in the final analysis, there is something wrong with the cells. After entering the human body, CGPP can generate new cells; it can quickly repair damaged cells through gene recombination; it can protect existing cells from external damage; it can correct diseased cells and restore them; it can prevent Cells mutate and give cells immunity; necrotic cells can be removed and excreted from the body.

Third, cell growth-promoting peptide (CGPP) can activate human growth hormone and promote tissue metabolism, which is beneficial to wound healing and organ function restoration. Cell growth-promoting peptide is the metabolic fuel of rapidly proliferating and differentiated cells (such as phagocytes, stem cells, etc.) in the body. It can promote lipid metabolism, improve the level of basal metabolism, and promote the metabolism of autologous tissues after entering cells.

Fourth, cell growth-promoting peptide (CGPP) contains antimicrobial peptides, which have a strong killing effect on a variety of bacteria, especially common pathogenic bacteria in the human body such as Staphylococcus aureus, Pseudomonas aeruginosa, and Streptococcus albicans. Afterwards the skin will not become infected. Therefore, after the use of cell growth-promoting peptide (CGPP), it is generally not necessary to use antibiotics and antibiotics.

It should be noted that in the process of wound healing, cell growth-promoting peptide (CGPP) can not only grow skin and muscle, but also grow blood vessels and nerves. It is not easy to achieve this. Only when all the conditions are met can the four types of organizations grow fully. So far, no other similar reports have been seen.

Seeing this, we will understand why it is said that cell growth-promoting peptide (CGPP) has solved this worldwide problem.

Let's look at two real-life cases.


Case 1 Ms. Liu, an 81-year-old patient, was paralyzed for 5 years after a stroke. She was unable to take care of herself and formed a bed sore with a radius of 12 cm. The soft tissue was festered and the sacrum was visible. Treatment with cell growth-promoting peptide (CGPP) products, without skin grafting, and without antibiotics, the decubitus completely healed after 5 months.


Case 2 The patient Mr. Zhou, 23 years old, was paralyzed below the chest due to the compression of the central nervous system by lymphoma. He was unable to take care of himself and developed bedsores. Drug resistance develops during the course of treatment, making it difficult to treat. Treatment with cell growth-promoting peptide (CGPP) products solved the problem of drug resistance, and the decubitus completely healed after half a year.

Wanli Medical uses cell growth-promoting peptide (CGPP) to treat bedsores without skin grafting, no scabs, fast healing and good curative effect. Moreover, the effect of cell growth-promoting peptide (CGPP) is soft and non-irritating, and generally there will be no adverse reactions in traditional medical treatment. It not only reduces pain and other discomforts, but also rebuilds the skin barrier, enhancing the skin's tolerance and resistance.

It can be said that cell growth-promoting peptide (CGPP) is the product of biotechnology, the crystallization of the labor and wisdom of scientific researchers, and will definitely play an important role in the long journey of human beings to overcome diseases and improve health.

(Written by Qiao Chunyang)